The evolution of immunotherapy resistance in mismatch repair-deficient colorectal cancer: A spatiotemporal perspective.
Immune checkpoint inhibitors (ICIs) have transformed the therapeutic landscape for mismatch repair deficient (dMMR) colorectal cancer; however, primary and acquired resistance remain significant challenges in clinical practice. This review proposes a working hypothesis that resistance can be conceptualized as following...